Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer

Immune checkpoint inhibitor (ICI) therapy has dramatically changed cancer treatment, opening novel opportunities to cure malignant diseases. To date, most prevalently targeted immune checkpoints are programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, LingJie, Lin, Caiji, Wang, Pengfei, Cao, Danli, Lin, Yiru, Wang, Wenxue, Zhao, Yufan, Shi, Yongwei, Gao, Zixiang, Kang, Xin, Zhang, Yuanyuan, Wang, Shuang, Wang, Jiaxing, Xu, Mengzhi, Liu, Huidi, Liu, Shu-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414047/
https://www.ncbi.nlm.nih.gov/pubmed/37576404
http://dx.doi.org/10.7150/jca.85966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414047/
https://www.ncbi.nlm.nih.gov/pubmed/37576404
http://dx.doi.org/10.7150/jca.85966

Ejemplares similares